Bristol Myers Squibb (BMY) Operating Expenses & History | Stock Alarm

Demo Sign up Log In

Bristol Myers Squibb · Operating Expenses

BMY Operating Expenses

Latest reported$20.67Bperiod endingJun 30, 2026

BMY Operating Expenses ($3.95B → $20.67B)

Annual operating expenses

High-resolution chart · PNG

BMY operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Operating Expenses — Annual fiscal periods (USD)
Period ending	Operating Expenses (USD)
Dec 31, 2025	20,535,000,000
Dec 31, 2024	28,445,000,000
Dec 31, 2023	26,118,000,000
Dec 31, 2022	26,918,000,000
Dec 31, 2021	27,908,000,000
Dec 31, 2020	28,568,000,000
Dec 31, 2019	12,154,000,000
Dec 31, 2018	10,980,000,000
Dec 31, 2017	11,316,000,000
Dec 31, 2016	9,991,000,000
Dec 31, 2015	10,921,000,000
Dec 31, 2014	10,233,000,000
Dec 31, 2013	8,835,000,000
Dec 31, 2012	9,079,000,000
Dec 31, 2011	9,009,000,000
Dec 31, 2010	8,257,000,000
Dec 31, 2009	8,229,000,000
Dec 31, 2008	7,376,000,000
Dec 31, 2007	9,602,000,000
Dec 31, 2006	9,131,000,000
Dec 31, 2005	9,131,000,000
Dec 31, 2004	8,927,000,000
Dec 31, 2003	8,314,000,000
Dec 31, 2002	7,473,000,000
Dec 31, 2001	7,376,000,000
Dec 31, 2000	7,471,000,000
Dec 31, 1999	7,775,000,000
Dec 31, 1998	7,334,000,000
Dec 31, 1997	8,390,000,000
Dec 31, 1996	7,666,000,000
Dec 31, 1995	6,963,000,000
Dec 31, 1994	5,969,000,000
Dec 31, 1993	6,289,000,000
Dec 31, 1992	6,634,000,000
Dec 31, 1991	5,709,000,000
Dec 31, 1990	5,281,000,000
Dec 31, 1989	5,646,000,000
Dec 31, 1988	4,489,000,000
Dec 31, 1987	3,950,000,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.